172 related articles for article (PubMed ID: 38503843)
21. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
22. The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.
Klein G; Rossi GC; Waxman AR; Arout C; Juni A; Inturrisi CE; Kest B
Neurosci Lett; 2009 Jul; 457(3):115-9. PubMed ID: 19429175
[TBL] [Abstract][Full Text] [Related]
23. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
24. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis.
Navarro-Zaragoza J; Martínez-Laorden E; Teruel-Fernández FJ; Gómez-Murcia V; Cánovas A; Milanés MV; Laorden ML; Almela P
Pharmacol Biochem Behav; 2021 Feb; 201():173106. PubMed ID: 33444599
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice.
Diaz SL; Hermida MP; Joannas LD; Olivera M; Ridolfi A; Villaamil EC; Balerio GN
Biopharm Drug Dispos; 2007 Sep; 28(6):283-9. PubMed ID: 17570125
[TBL] [Abstract][Full Text] [Related]
26. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.
Luster BR; Cogan ES; Schmidt KT; Pati D; Pina MM; Dange K; McElligott ZA
Addict Biol; 2020 May; 25(3):e12748. PubMed ID: 30963693
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
29. Next generation effects of female adolescent morphine exposure: sex-specific alterations in response to acute morphine emerge before puberty.
Vassoler FM; Johnson-Collins NL; Carini LM; Byrnes EM
Behav Pharmacol; 2014 Apr; 25(2):173-81. PubMed ID: 24561499
[TBL] [Abstract][Full Text] [Related]
30. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN
Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881
[TBL] [Abstract][Full Text] [Related]
31. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
32. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
33. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
34. Slow-sustained delivery of naloxone reduces typical naloxone-induced precipitated opioid withdrawal effects in male morphine-dependent mice.
Lewter LA; Johnson MC; Treat AC; Kassick AJ; Averick S; Kolber BJ
J Neurosci Res; 2022 Jan; 100(1):339-352. PubMed ID: 32772457
[TBL] [Abstract][Full Text] [Related]
35. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Dong Z; Han H; Cao J; Xu L
Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
[TBL] [Abstract][Full Text] [Related]
36. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
[TBL] [Abstract][Full Text] [Related]
37. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
38. Modulation of morphine physical dependence and discriminative stimulus effects by ovarian hormones: Role of estradiol.
Smith MA; Armas SP; Schmidt KT
Pharmacol Biochem Behav; 2022 Jul; 218():173431. PubMed ID: 35850178
[TBL] [Abstract][Full Text] [Related]
39. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine reduces somatic withdrawal in a mouse model of early-life morphine exposure.
Lepore G; Morley-McLaughlin T; Davidson N; Han C; Masese C; Reynolds G; Saltz V; Robinson SA
Drug Alcohol Depend; 2023 Jul; 248():109938. PubMed ID: 37267743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
